Mon, May 10, 2010
Sun, May 9, 2010
Sat, May 8, 2010
Fri, May 7, 2010
Thu, May 6, 2010
Mon, January 11, 2010
Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010
Mon, January 4, 2010
[ Mon, Jan 04th 2010 ] - Market Wire
Cordani Becomes CIGNA CEO
Thu, December 31, 2009
[ Thu, Dec 31st 2009 ] - Market Wire
Quit the Board
Wed, December 30, 2009
Tue, December 29, 2009
Mon, December 28, 2009
Thu, December 24, 2009
Wed, December 23, 2009
Tue, December 22, 2009
Mon, December 21, 2009
Fri, December 18, 2009

Amedisys Acquires New Jersey Home Health Agency


//health-fitness.news-articles.net/content/2010/ .. isys-acquires-new-jersey-home-health-agency.html
Published in Health and Fitness on Monday, January 4th 2010 at 10:30 GMT by Market Wire   Print publication without navigation


BATON ROUGE, La.--([ BUSINESS WIRE ])--Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health nursing companies, today announced that it has received the regulatory approvals from the state of New Jersey and that it has completed the acquisition of the home health operations of Hackensack University Medical Center. This acquisition represents Amedisys' initial entry into the home health business in New Jersey, a certificate of need (CON) state. The agency has annualized revenue of approximately $19 million and serves Bergen and Hudson counties.

"We welcome the employees from the Hackensack home health agency into the Amedisys family. We are very excited about this opportunity to provide services in New Jersey"

"We welcome the employees from the Hackensack home health agency into the Amedisys family. We are very excited about this opportunity to provide services in New Jersey," stated William F. Borne, Chief Executive Officer of Amedisys, Inc. "This marks our initial entrance into New Jersey, a state with a significant number of Medicare beneficiaries. We look forward to building on the excellent care and service the agency currently provides to the patients in this community by introducing Amedisys clinical programs, providing additional financial and operational resources, and expanding business development efforts."

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the NASDAQ Global Select Market under the symbol "AMED".

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate" or similar expressions.Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.Many of the factors that could cause or contribute to such differences are described in the Company's periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management's control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Our company website address is [ www.amedisys.com ]. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page.We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information.In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").

Additional information on the Company can be found at:

[ www.amedisys.com ]


Publication Contributing Sources